Ceperognastat

N/A

Report date: 2025/05/20 15:34:34
NME

Base Information

Drug NameCeperognastat
Drug Alias NameLY-3372689
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein O-GlcNAcase inhibitors
TargetsProtein O-GlcNAcase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A